Related Experiment Video
Updated: Jun 13, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Prognostic information in administrative co-morbidity data following coronary artery bypass grafting
Steen Zabell Abildstrøm1, Anders Hvelplund, Søren Rasmussen
1National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark. stabil@dadlnet.dk
Insights
Administrative data provide prognostic information for 30-day mortality after coronary artery bypass grafting (CABG) that is comparable to the established EuroSCORE. This finding highlights the utility of administrative data in predicting patient outcomes following CABG surgery.
Area of Science:
- Cardiovascular Surgery
- Health Informatics
- Biostatistics
Background:
- Predicting patient outcomes after coronary artery bypass grafting (CABG) is crucial for clinical decision-making and resource allocation.
- The European System for Cardiac Operative Risk Evaluation (EuroSCORE) is a widely used tool for assessing operative risk.
- Administrative data, often readily available, may offer valuable prognostic information.
Purpose of the Study:
- To evaluate the prognostic value of administrative data for 30-day mortality after CABG.
- To compare the predictive performance of a co-morbidity index derived from administrative data with the EuroSCORE.
Main Methods:
- A co-morbidity index was calculated using administrative data from the Danish National Patient Register for admissions up to one year prior to CABG.
- CABG procedures were categorized as isolated/non-isolated and acute/non-acute.
- The prognostic power of the co-morbidity index was compared to the EuroSCORE using logistic regression analysis on a cohort of 20,078 patients.
Main Results:
- The co-morbidity index derived from administrative data demonstrated significant prognostic information for 30-day mortality (c-statistic = 0.81).
- The prognostic power of the administrative co-morbidity index was comparable to that of the EuroSCORE (c-statistic = 0.79).
Conclusions:
- Administrative data can be effectively utilized to create a co-morbidity index with significant prognostic value for 30-day mortality after CABG.
- The prognostic performance of this administrative data-based index is equivalent to that of the clinical EuroSCORE, suggesting its utility in risk prediction.
Objectives:
The aim of this study was to evaluate the prognostic information obtainable from administrative data with respect to 30-day mortality following coronary artery bypass grafting (CABG) and to compare it with the European System for Cardiac Operative Risk Evaluation (EuroSCORE) recorded in a clinical database.
Methods:
We used a co-morbidity index calculated from administrative data in the Danish National Patient Register by means of all admissions 1 year prior to CABG. In addition, each CABG was categorised as being isolated or not, and acute or not. The prognostic power of the co-morbidity index was compared to that achieved using EuroSCORE from a clinical database comprising information on all patients treated with CABG in Denmark. The outcome was all-cause mortality within 30 days after CABG and the prognostic power was evaluated using logistic regression analyses.
Results:
We identified 20078 patients treated with CABG from 2000 to 2007 with a complete registration of the total additive EuroSCORE in the clinical database. The co-morbidity index carried significant prognostic information regarding 30-day mortality (c-statistic 0.81). The prognostic power of the co-morbidity index was equal to that of the EuroSCORE (c-statistic 0.79).
Conclusions:
A standard co-morbidity index based on administrative data as well as on clinical data has proven equally useful for prediction of mortality amongst CABG patients.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Peripheral Artery Disease V: Postoperative Nursing Management
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
